United States · FDA National Drug Code directory
Fulvestrant
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43598-262_67af235f-7f8b-da5b-5eb6-91d0b20b2a9e
- Product NDC
- 43598-262
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Fulvestrant
- Labeler
- Dr.Reddy's Laboratories Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20231231
- Source listing expiry
- 20261231
Source-listed ingredients
- FULVESTRANT — 50 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 SYRINGE, GLASS in 1 CARTON (43598-262-23) / 5 mL in 1 SYRINGE, GLASS (43598-262-11) · 43598-262-23
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →